Literature DB >> 26028516

Of mothers and myelin: Aberrant myelination phenotypes in mouse model of Angelman syndrome are dependent on maternal and dietary influences.

Mark D Grier1, Robert P Carson2, Andre H Lagrange3.   

Abstract

Angelman syndrome (AS) is a neurodevelopmental disorder characterized by a number of neurological problems, including developmental delay, movement disorders, and epilepsy. AS results from the loss of UBE3A (an imprinted gene) expressed from the maternal chromosome in neurons. Given the ubiquitous expression of Ube3a and the devastating nature of AS, the role of environmental and maternal effects has been largely ignored. Severe ataxia, anxiety-like behaviors and learning deficits are well-documented in patients and AS mice. More recently, clinical imaging studies of AS patients suggest myelination may be delayed or reduced. Utilizing a mouse model of AS, we found disrupted expression of cortical myelin proteins, the magnitude of which is influenced by maternal status, in that the aberrant myelination in the AS pups of AS affected mothers were more pronounced than those seen in AS pups raised by unaffected (Ube3a (m+/p-)) Carrier mothers. Furthermore, feeding the breeding mothers a higher fat (11% vs 5%) diet normalizes these myelin defects. These effects are not limited to myelin proteins. Since AS mice have abnormal stress responses, including altered glucocorticoid receptor (GR) expression, we measured GR expression in pups from Carrier and affected AS mothers. AS pups had higher GR expression than their WT littermates. However, we also found an effect of maternal status, with reduced GR levels in pups from affected mothers compared to genotypically identical pups raised by unaffected Carrier mothers. Taken together, our findings suggest that the phenotypes observed in AS mice may be modulated by factors independent of Ube3a genotype. Published by Elsevier B.V.

Entities:  

Keywords:  Angelman syndrome; Breeding; E6AP; Maternal effects; Myelin; Ube3a

Mesh:

Substances:

Year:  2015        PMID: 26028516      PMCID: PMC4496262          DOI: 10.1016/j.bbr.2015.05.045

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  38 in total

1.  Abnormal myelination in Angelman syndrome.

Authors:  Manuel Castro-Gago; Carmen Gómez-Lado; Jesús Eirís-Puñal; Vanessa María Rodríguez-Mugico
Journal:  Eur J Paediatr Neurol       Date:  2009-08-31       Impact factor: 3.140

Review 2.  Schwann cells: origins and role in axonal maintenance and regeneration.

Authors:  Kanav Bhatheja; Jeffrey Field
Journal:  Int J Biochem Cell Biol       Date:  2006-05-27       Impact factor: 5.085

3.  Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation.

Authors:  Daren Low; Ken-Shiung Chen
Journal:  Eur J Hum Genet       Date:  2010-06-23       Impact factor: 4.246

4.  Reversal of reduced parvalbumin neurons in hippocampus and amygdala of Angelman syndrome model mice by chronic treatment of fluoxetine.

Authors:  Swetha K Godavarthi; Ankit Sharma; Nihar Ranjan Jana
Journal:  J Neurochem       Date:  2014-04-25       Impact factor: 5.372

Review 5.  Myelin sheaths: glycoproteins involved in their formation, maintenance and degeneration.

Authors:  R H Quarles
Journal:  Cell Mol Life Sci       Date:  2002-11       Impact factor: 9.261

6.  Maternal genotype influences behavioral development of 3×Tg-AD mouse pups.

Authors:  Caitlin E Blaney; Rhian K Gunn; Kurt R Stover; Richard E Brown
Journal:  Behav Brain Res       Date:  2013-05-24       Impact factor: 3.332

7.  The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation.

Authors:  Kathryn H Condon; Jianghai Ho; Camenzind G Robinson; Cyril Hanus; Michael D Ehlers
Journal:  J Neurosci       Date:  2013-02-27       Impact factor: 6.167

Review 8.  Clinical and genetic aspects of Angelman syndrome.

Authors:  Charles A Williams; Daniel J Driscoll; Aditi I Dagli
Journal:  Genet Med       Date:  2010-07       Impact factor: 8.822

9.  Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model.

Authors:  Linyan Meng; Richard Erwin Person; Wei Huang; Ping Jun Zhu; Mauro Costa-Mattioli; Arthur L Beaudet
Journal:  PLoS Genet       Date:  2013-12-26       Impact factor: 5.917

10.  Both maternal and pup genotype influence ultrasonic vocalizations and early developmental milestones in tsc2 (+/-) mice.

Authors:  Emily A Greene-Colozzi; Abbey R Sadowski; Elyza Chadwick; Peter T Tsai; Mustafa Sahin
Journal:  Epilepsy Res Treat       Date:  2014-08-04
View more
  5 in total

1.  Early motor phenotype detection in a female mouse model of Rett syndrome is improved by cross-fostering.

Authors:  Annie Vogel Ciernia; Michael C Pride; Blythe Durbin-Johnson; Adriana Noronha; Alene Chang; Dag H Yasui; Jacqueline N Crawley; Janine M LaSalle
Journal:  Hum Mol Genet       Date:  2017-05-15       Impact factor: 6.150

Review 2.  Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder?

Authors:  Juliana Magdalon; Sandra M Sánchez-Sánchez; Karina Griesi-Oliveira; Andréa L Sertié
Journal:  Int J Mol Sci       Date:  2017-03-18       Impact factor: 5.923

3.  Autism gene Ube3a and seizures impair sociability by repressing VTA Cbln1.

Authors:  Vaishnav Krishnan; David C Stoppel; Yi Nong; Mark A Johnson; Monica J S Nadler; Ekim Ozkaynak; Brian L Teng; Ikue Nagakura; Fahim Mohammad; Michael A Silva; Sally Peterson; Tristan J Cruz; Ekkehard M Kasper; Ramy Arnaout; Matthew P Anderson
Journal:  Nature       Date:  2017-03-15       Impact factor: 49.962

4.  Transcriptomic characterization of MRI contrast with focus on the T1-w/T2-w ratio in the cerebral cortex.

Authors:  Jacob Ritchie; Spiro P Pantazatos; Leon French
Journal:  Neuroimage       Date:  2018-03-20       Impact factor: 6.556

5.  Experience-Dependent Changes in Myelin Basic Protein Expression in Adult Visual and Somatosensory Cortex.

Authors:  Kathryn M Murphy; Steven J Mancini; Katherine V Clayworth; Keon Arbabi; Simon Beshara
Journal:  Front Cell Neurosci       Date:  2020-03-17       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.